163 related articles for article (PubMed ID: 36730446)
1. Advances in innovative delivery systems for antiglaucoma drugs.
Chen X; Shen T
Curr Opin Ophthalmol; 2023 Mar; 34(2):123-128. PubMed ID: 36730446
[TBL] [Abstract][Full Text] [Related]
2. Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.
Kompella UB; Hartman RR; Patil MA
Prog Retin Eye Res; 2021 May; 82():100901. PubMed ID: 32891866
[TBL] [Abstract][Full Text] [Related]
3. [Progression of drug delivery system for glaucoma].
Xu Y; Lyu L
Zhonghua Yan Ke Za Zhi; 2014 Dec; 50(12):946-51. PubMed ID: 25619186
[TBL] [Abstract][Full Text] [Related]
4. Sustained release ocular drug delivery systems for glaucoma therapy.
Al-Qaysi ZK; Beadham IG; Schwikkard SL; Bear JC; Al-Kinani AA; Alany RG
Expert Opin Drug Deliv; 2023; 20(7):905-919. PubMed ID: 37249548
[TBL] [Abstract][Full Text] [Related]
5. Sustained drug delivery for glaucoma: current data and future trends.
Aref AA
Curr Opin Ophthalmol; 2017 Mar; 28(2):169-174. PubMed ID: 27764023
[TBL] [Abstract][Full Text] [Related]
6. Sustained drug delivery in glaucoma.
Knight OJ; Lawrence SD
Curr Opin Ophthalmol; 2014 Mar; 25(2):112-7. PubMed ID: 24463419
[TBL] [Abstract][Full Text] [Related]
7. Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys.
Fuwa M; Shimazaki A; Odani-Kawabata N; Kirihara T; Taniguchi T; Iwamura R; Yoneda K; Kato M; Morishima K; Shams NK
J Ocul Pharmacol Ther; 2021 May; 37(4):223-229. PubMed ID: 33600237
[No Abstract] [Full Text] [Related]
8. Novel drug delivery systems for glaucoma.
Lavik E; Kuehn MH; Kwon YH
Eye (Lond); 2011 May; 25(5):578-86. PubMed ID: 21475311
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
[TBL] [Abstract][Full Text] [Related]
10. Current opinion in ophthalmology: novel glaucoma devices in the pipeline.
Ittoop SM; Seibold LK; Kahook MY
Curr Opin Ophthalmol; 2019 Mar; 30(2):117-124. PubMed ID: 30575619
[TBL] [Abstract][Full Text] [Related]
11. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Zhang L; Weizer JS; Musch DC
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010746. PubMed ID: 28231380
[TBL] [Abstract][Full Text] [Related]
12. Delivery of antiglaucoma drugs: ocular vs systemic absorption.
Urtti A
J Ocul Pharmacol; 1994; 10(1):349-57. PubMed ID: 8207339
[TBL] [Abstract][Full Text] [Related]
13. Recent advancements in nanomaterial-laden contact lenses for diagnosis and treatment of glaucoma, review and update.
Baghban R; Talebnejad MR; Meshksar A; Heydari M; Khalili MR
J Nanobiotechnology; 2023 Nov; 21(1):402. PubMed ID: 37919748
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles.
Kim YC; Edelhauser HF; Prausnitz MR
Invest Ophthalmol Vis Sci; 2014 Sep; 55(11):7387-97. PubMed ID: 25212782
[TBL] [Abstract][Full Text] [Related]
15. Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications.
Cho WH; Lai IC; Fang PC; Chien CC; Tseng SL; Lai YH; Huang YT; Kuo MT
J Glaucoma; 2018 Feb; 27(2):176-183. PubMed ID: 29240600
[TBL] [Abstract][Full Text] [Related]
16. Dendritic Oligoethylenimine Decorated Liposome with Augmented Corneal Retention and Permeation for Efficient Topical Delivery of Antiglaucoma Drugs.
Qiu L; Zhang J; Liu S; Li B; Wang J; Tang J; Pu X; Huang Z; Liao X; Yin G
Nano Lett; 2023 Dec; 23(23):11193-11202. PubMed ID: 38039401
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery by contact lens in spontaneously glaucomatous dogs.
Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
[TBL] [Abstract][Full Text] [Related]
18. Extended drug delivery by contact lenses for glaucoma therapy.
Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
J Control Release; 2012 Aug; 162(1):152-8. PubMed ID: 22721817
[TBL] [Abstract][Full Text] [Related]
19. Patient Acceptance of Sustained Glaucoma Treatment Strategies.
Varadaraj V; Kahook MY; Ramulu PY; Pitha IF
J Glaucoma; 2018 Apr; 27(4):328-335. PubMed ID: 29462013
[TBL] [Abstract][Full Text] [Related]
20. Effect of Antiglaucoma Medicine on Intraocular Pressure in DBA/2J Mice.
Sawada K; Hiraoka M; Ohguro H
Ophthalmic Res; 2016; 55(4):205-11. PubMed ID: 26942413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
